Related Experiment Videos
Membranous glomerulonephritis in chronic lymphocytic leukemia
Panayiotis D Ziakas1, Stavroula Giannouli, Erasmia Psimenou
1Department of Pathophysiology, Medical School, National University of Athens, M. Asias 75, Goudi, 11527 Athens, Greece.
American Journal of Hematology
|June 30, 2004
Summary
This study details a rare case of nephrotic syndrome in chronic lymphocytic leukemia (CLL). Combination therapy effectively treated both CLL and improved kidney function.
Area of Science:
- Nephrology
- Hematology
- Oncology
Background:
- Chronic lymphocytic leukemia (CLL) is a hematologic malignancy.
- Nephrotic syndrome is a kidney disorder characterized by heavy proteinuria.
- The association between CLL and nephrotic syndrome is uncommon.
Observation:
- A patient presented with chronic lymphocytic leukemia and nephrotic syndrome.
- Renal biopsy showed membranous glomerulonephritis with interstitial lymphocytic infiltration.
- The infiltration was monoclonal, consistent with CLL.
Findings:
- Combination therapy with cyclophosphamide, vincristine, and prednisone (COP) was administered.
- The treatment induced an effective response in chronic lymphocytic leukemia.
- Significant improvement in renal function and reduction in proteinuria were observed.
Implications:
- This case highlights a potential paraneoplastic manifestation of CLL.
- COP chemotherapy can be effective in managing renal complications of CLL.
- Early diagnosis and treatment may improve outcomes for patients with CLL-associated nephrotic syndrome.